Stay updated on Dapirolizumab Pegol Safety in Lupus Clinical Trial
Sign up to get notified when there's something new on the Dapirolizumab Pegol Safety in Lupus Clinical Trial page.

Latest updates to the Dapirolizumab Pegol Safety in Lupus Clinical Trial page
- Check3 days agoChange DetectedThe page has removed specific future updates regarding the modernization of ClinicalTrials.gov data ingest and the associated API user input opportunity, while also deleting a previous revision date.SummaryDifference5%
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference4%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has updated its version from v2.16.1 to v2.16.2 and changed the date from May 16, 2025, to May 31, 2025.SummaryDifference0.6%
- Check39 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check46 days agoChange DetectedThe date has been updated from May 2, 2025, to May 16, 2025.SummaryDifference0.3%
- Check60 days agoChange DetectedThe date has been updated from April 18, 2025, to May 2, 2025.SummaryDifference0.6%
Stay in the know with updates to Dapirolizumab Pegol Safety in Lupus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapirolizumab Pegol Safety in Lupus Clinical Trial page.